Default image

Justin M

OpGen (OPGN) surges on business update and FDA clearance

OpGen (OPGN) surges on business update and FDA clearance

OpGen (OPGN), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that total preliminary unaudited revenue for the third quarter of 2021 was approximately $1.2 million, up from $1.1 million…